BDX

BECTON DICKINSN
NYSE

Real-time Quotes | Nasdaq Last Sale

221.16
-4.43
-1.96%
Closed 17:19 09/24 EDT
OPEN
226.00
PREV CLOSE
225.59
HIGH
226.47
LOW
220.04
VOLUME
1.52M
TURNOVER
--
52 WEEK HIGH
286.72
52 WEEK LOW
197.75
MARKET CAP
64.11B
P/E (TTM)
77.88
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Everything Investors Need to Know About Coronavirus Tests
MotleyFool.com · 1d ago
BD submits pre-market approval supplement for use of ThinPrep Pap Test PreservCyt solution with HPV assay
Becton, Dickinson or BD ([[BDX]] +2.0%) has submitted a pre-market approval ((PMA)) supplement to FDA for the use of the ThinPrep Pap Test PreservCyt Solution vial as an approved sample type for its Onclarity human
Seekingalpha · 1d ago
BD Submits Pre-Market Approval Supplement To FDA To Enable ThinPrep Pap Test PreservCyt Solution To Be Used With BD Onclarity HPV Assay
FRANKLIN LAKES, N.J., Sept. 23, 2020 /PRNewswire/ --BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced that it has submitted a pre-market approval (PMA)
Benzinga · 1d ago
BD Submits Pre-Market Approval Supplement to FDA to Enable ThinPrep® Pap Test™ PreservCyt® Solution to be Used with the BD Onclarity™ HPV Assay
PR Newswire · 1d ago
BD Announces FDA Classifications for August 4th Recalls of BD Alaris System Hardware for Keypads, Incorrect Module Types and/or Sizes, and Channel Error
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today provided an update on previously announced voluntary recalls of the BD Alaris™ System.
PR Newswire · 3d ago
A Look Into Becton, Dickinson's Debt
Over the past three months, shares of Becton, Dickinson (NYSE: BDX) rose by 1.29%. Before we understand the importance of debt, let us look at how much debt Becton, Dickinson has.Becton, Dickinson's Debt Based on Becton, Dickinson's financial statement as of August 6, 2020, long-term debt is
Benzinga · 3d ago
BD Announces FDA Classifications For August 4th Recalls Of BD Alaris System Hardware For Keypads, Incorrect Module Types And/Or Sizes, And Channel Error
FRANKLIN LAKES, N.J., Sept. 21, 2020 /PRNewswire/ --BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today provided an update on previously announced voluntary recalls
Benzinga · 3d ago
FOCUS-U.S. plans for hundreds of millions of cheap, fast COVID-19 tests
Manufacturing and government sources tell Reuters that more than half a dozen so-called antigen tests will likely be authorized by the end of October. U.S. regulators in recent months have authorized antigen tests from Abbott Laboratories , Becton Dickinson & Co , Quidel Corp and LumiraDX. When
Reuters · 09/17 12:00
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of BDX. Analyze the recent business situations of BECTON DICKINSN through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 17 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average BDX stock price target is 282.38 with a high estimate of 300.00 and a low estimate of 255.00.
EPS
Institutional Holdings
Institutions: 1.48K
Institutional Holdings: 242.73M
% Owned: 83.74%
Shares Outstanding: 289.87M
TypeInstitutionsShares
Increased
510
11.23M
New
99
2.47M
Decreased
494
11.67M
Sold Out
94
1.46M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.71%
Healthcare Equipment & Supplies
-0.59%
Key Executives
Chairman/Director
Vincent Forlenza
President/Chief Executive Officer/Chief Operating Officer/Director
Thomas Polen
Chief Financial Officer/Executive Vice President/Chief Administrative Officer
Christopher Reidy
Chief Human Resource Officer/Executive Vice President/Director of Human Resources
Betty Larson
Executive Vice President/General Counsel
Samrat Khichi
Corporate Executive
William Tozzi
Executive Vice President
James Borzi
Executive Vice President
Simon Campion
Executive Vice President/Chief Technology Officer
John DeFord
Executive Vice President
Roland Goette
Executive Vice President
Patrick Kaltenbach
Executive Vice President
James Lim
Executive Vice President
Ching leong
Executive Vice President
Alberto Mas
Senior Vice President
Charles Bodner
Chief Accounting Officer/Vice President/Controller
Thomas Spoerel
Independent Director
Catherine Burzik
Independent Director
R. Andrew Eckert
Independent Director
Christopher Ian Jones
Independent Director
Claire Fraser
Independent Director
Jeffrey Henderson
Independent Director
Christopher Jones
Independent Director
Marshall Larsen
Independent Director
David Melcher
Independent Director
Claire Pomeroy
Independent Director
Rebecca Rimel
Independent Director
Timothy Ring
Independent Director
Bertram Scott
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
07/27/2020
Dividend USD 0.79
09/08/2020
04/28/2020
Dividend USD 0.79
06/08/2020
01/27/2020
Dividend USD 0.79
03/09/2020
11/25/2019
Dividend USD 0.79
12/09/2019
07/22/2019
Dividend USD 0.77
09/06/2019
04/29/2019
Dividend USD 0.77
06/06/2019
01/21/2019
Dividend USD 0.77
03/07/2019
11/19/2018
Dividend USD 0.77
12/07/2018
07/24/2018
Dividend USD 0.75
09/06/2018
04/23/2018
Dividend USD 0.75
06/07/2018
01/23/2018
Dividend USD 0.75
03/08/2018
11/21/2017
Dividend USD 0.75
12/07/2017
07/27/2017
Dividend USD 0.73
09/07/2017
05/24/2017
Dividend USD 0.73
06/07/2017
01/24/2017
Dividend USD 0.73
03/08/2017
11/22/2016
Dividend USD 0.73
12/07/2016
07/27/2016
Dividend USD 0.66
09/07/2016
05/25/2016
Dividend USD 0.66
06/07/2016
01/26/2016
Dividend USD 0.66
03/08/2016
11/24/2015
Dividend USD 0.66
12/08/2015
07/29/2015
Dividend USD 0.6
09/04/2015
05/20/2015
Dividend USD 0.6
06/05/2015
01/27/2015
Dividend USD 0.6
03/06/2015
12/08/2014
Dividend USD 0.6
12/08/2014
07/22/2014
Dividend USD 0.545
09/05/2014
05/20/2014
Dividend USD 0.545
06/05/2014
01/28/2014
Dividend USD 0.545
03/06/2014
11/26/2013
Dividend USD 0.545
12/06/2013
07/23/2013
Dividend USD 0.495
09/05/2013
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About BDX
Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including diabetes care, medication and procedural solutions, medication management solutions and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Life Sciences segment consists of various business units, including preanalytical systems, diagnostic systems and biosciences.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Becton Dickinson and Co stock information, including NYSE:BDX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BDX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BDX stock methods without spending real money on the virtual paper trading platform.